Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy.
Sabini E, Sisti E, Coco B, Leo M, Ionni I, Menconi F, Profilo MA, Mazzi B, Rocchi R, Latrofa F, Vitti P, Brunetto M, Marcocci C, Marinò M.
Sabini E, et al. Among authors: marcocci c.
J Endocrinol Invest. 2016 Nov;39(11):1323-1327. doi: 10.1007/s40618-016-0518-5. Epub 2016 Jul 27.
J Endocrinol Invest. 2016.
PMID: 27465669